Symfi Tablet, Film Coated
Product Images NDC 49502-475

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Symfi (NDC 49502-475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Symfi (efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate) Tablets 600 mg/300 mg/300 mg Carton Label (Image 01)

This is a description of a pharmaceutical product called SYMFI. It is indicated for the treatment of HIV-1 infection in adults and teenagers weighing at least 35 kg. Each bottle contains 30 tablets with the NDC numbers 49502-475-93 and 49502-475-99. The active ingredients are efavirenz, lamivudine, and tenofovir disoproxil fumarate. The tablet strength is 600 mg/300 mg/300 mg, respectively. The item should be stored at 20-25°C (68-77°F). The inadvertently added some spaces, special characters, and typos, but the information provided is still useful.*

FDA Label Image

Efavirenz Structural Formula (Image 02)

FDA Label Image

Lamivudine Structural Formula (Image 03)

FDA Label Image

Tenofovir Disoproxil Fumarate Structural Formula (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.